Characterisation of a Novel Producer, the Antimicrobial Properties and the Molecular Target of Zelkovamycin
Publication Date
July 24, 2020
Creator
Abstract
The rise of antimicrobial resistance poses a threat to the treatment of infections caused by pathogenic and opportunistic bacteria, including Staphylococcus aureus and Pseudomonas aeruginosa.
In a time of relentless search for new antibiotics, the recent isolation of a novel producer of zelkovamycin offered the opportunity to investigate the unidentified biosynthetic gene cluster of the antibiotic and encouraged the elucidation of its antimicrobial properties and uncertain target.
In the first part of this work, the polyphasic characterisation the novel actinomycete strain 32-07 is presented. Based on its genome and 16S rRNA sequence, the microorganism was found to belong to the genus Actinomadura. Its phenotypic and genotypic characteristics, however, distinguished the isolate from its closest relative and its classification as Actinomadura graeca was therefore proposed. The new species was also confirmed as a producer of the antibiotic zelkovamycin, for which the putative biosynthetic cluster was identified.
The antimicrobial properties of zelkovamycin against P. aeruginosa PAO1-L and S. aureus SH1000 are elucidated in the second part of the study. The antibiotic was confirmed effective against S. aureus and its previously unreported activity against P. aeruginosa was uncovered and characterised. In both species, zelkovamycin appeared to easily permeate cell membranes, although a marked increase in its activity was recorded against an efflux-deficient P. aeruginosa mutant. It is therefore postulated that zelkovamycin may be subject to active efflux in Gram-negative bacteria.
The last part of this manuscript focuses on the investigation and identification of the molecular target of zelkovamycin. Each of several single amino acid substitutions in a single protein were found to confer S. aureus high resistance to the antibiotic, confirming the role of the protein as the target for zelkovamycin.
Item Type
ethesis
Thesis Type
PhD
Supervisors
Associated Schools / Departments
School of Pharmacy (UK)
eprints ID
60112
UoN Repository URI
Except where otherwise noted, this item's license is described as
File(s)![Thumbnail Image]()
Name
PhD Thesis.pdf
Type
Full-text
Description
Examined
Size
7.97 MB
Format
Adobe PDF
Checksum (MD5)
f177a5169db6018a9d9441e0ea6cb607